Decoy Therapeutics is trading 5.40% up at $2.93 in pre-market on September 8, 2026, with no fresh company-specific announcement, earnings release, or filing identified as explaining the move.
- Latest notable updates were earlier biotechnology developments, including July’s Ebola Zaire testing announcement and August’s intellectual-property expansion.
- Broader markets are weaker, so global sentiment does not clearly explain the gain.